Buprenorphine Hydrochloride And Naloxone Hydrochloride Dihydrate Tablet
Product Images NDC 0406-8020

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Buprenorphine Hydrochloride And Naloxone Hydrochloride Dihydrate (NDC 0406-8020). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Specgx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Buprenorphine HCl And Naloxone HCl Dihydrate Subli 1

Chemical structure of Buprenorphine Hydrochloride, showing its molecular framework including hydroxyl, methoxy, and cyclopropyl groups, along with the hydrochloride component.*

FDA Label Image

Buprenorphine HCl And Naloxone HCl Dihydrate Subli 2

Chemical structure of Buprenorphine Hydrochloride and Naloxone Hydrochloride Dihydrate, showing molecular bonds and functional groups including hydroxyl, ketone, and hydrochloride with water of hydration molecules.*

FDA Label Image

Buprenorphine HCl And Naloxone HCl Dihydrate Subli 3

An instructional illustration showing a person placing a sublingual tablet underneath their tongue using the fingers. The open mouth reveals the tongue and lower teeth, highlighting the proper placement of the tablet for sublingual administration.*

FDA Label Image

Buprenorphine HCl And Naloxone HCl Dihydrate Subli 4

Label for Buprenorphine and Naloxone Sublingual Tablets, strength 2 mg/0.5 mg, in a 30-tablet package. The label includes prescribing information highlights such as dispensing instructions, storage conditions, and strength details. Manufactured for SpecGx LLC, located in Webster Groves, MO. The label also features the National Drug Code (NDC) 0406-8005-03 and a barcode.*

FDA Label Image

Buprenorphine HCl And Naloxone HCl Dihydrate Subli 5

Label for Buprenorphine and Naloxone Sublingual Tablets, 8 mg/2 mg strength. The carton contains 30 tablets for sublingual use, manufactured by SpecGx LLC. The label includes dosage details specifying each tablet contains 8 mg buprenorphine and 2 mg naloxone, storage instructions at 20° to 25°C, and a pharmacist advisory to dispense the Medication Guide. The label also includes a barcode and the NDC number 0406-8020-03.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.